BGLC
#5022
BioNexus Gene Lab Corp - Common stock
1.9 3 USD
+0.01%
Sector: Basic Materials
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.05%
Monthly Change
-12.27%
6 month change
-14.04%
Year Change
-14.04%
Previous Close
1.9 1
Open
1.9 3
Low
1.9 3
High
1.9 3
Volume
1
Financials
- Market Capitalization 4.67 M
- Employee 1
- Founded 2017
- CEO N/A
- Website www.bionexusgenelab.com
- Headquarter Wyoming, United States
- FIGI BBG00N70PLY0
- Industry Specialty Chemicals
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4915 |  SNES SenesTech, Inc. - Common Stock | 1.39 USD | -1.42% | -7.33% | -17.26% | -40.60% | 7.37 M USD | ||
| 4937 |  YMAT J-Star Holding Co., Ltd. - Class A Ordinary Shares | 0.47 USD | -12.96% | -16.07% | -41.98% | -89.53% | 6.56 M USD | ||
| 5120 |  CNEY CN Energy Group Inc. - Class A Ordinary Shares | 0.48 USD | -7.69% | 0.00% | -46.67% | -81.54% | 2.39 M USD | ||
| 5440 |  SSL Sasol Ltd American Depositary Shares | 10.33 USD | +2.79% | +7.94% | -24.71% | +100.58% | 0 USD |
Frequently asked questions about BioNexus Gene Lab Corp - Common stock
What is the BioNexus Gene Lab Corp - Common stock stock price today?
The current price of BioNexus Gene Lab Corp - Common stock (BGLC) is 1.9300000000000002. Over the past 24 hours, the stock has changed by +1.05%. Follow the BGLC chart for real-time price dynamics.
What is the stock ticker of BioNexus Gene Lab Corp - Common stock?
BioNexus Gene Lab Corp - Common stock trades under the ticker BGLC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioNexus Gene Lab Corp - Common stock stock going up?
BGLC has changed by -5.85% over the last week, -12.27% over the last month, and -14.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioNexus Gene Lab Corp - Common stock net income for the last quarter?
BioNexus Gene Lab Corp - Common stock reported net income of -543.58 K for the last quarter. The previous quarter showed -1.04 M, which means net income changed by +47.54%.
How many employees does BioNexus Gene Lab Corp - Common stock have?
As of the latest available data, BioNexus Gene Lab Corp - Common stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioNexus Gene Lab Corp - Common stock EBITDA?
BioNexus Gene Lab Corp - Common stock EBITDA is -569.88 K, and its EBITDA margin is -2 494.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioNexus Gene Lab Corp - Common stock stock?
You can buy BioNexus Gene Lab Corp - Common stock (BGLC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioNexus Gene Lab Corp - Common stock stock?
Investing in BioNexus Gene Lab Corp - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BGLC chart and related analysis on metatrader.com as part of your research.